ClinicalTrials HQ

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Suzhou Zelgen Biopharmaceuticals Co.,Ltd

Explore linked clinical trials.

23 results ยท Page 1 of 1

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
ZG005 Plus Etoposide and Cisplatin vs. Etoposide and Cisplatin as First-Line Treatment for Advanced Neuroendocrine CarcinomaNeoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumorNot yet recruitingPhase 32026-09-22NCT07833839
ZG005 Plus Bevacizumab vs Sintilimab Plus Bevacizumab as First-Line Therapy for Advanced HepatocellularDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmNot yet recruitingPhase 32026-09-10NCT07813572
A Pharmacokinetic Study of Gecacitinib Hydrochloride Tablets in Healthy Adult Participants.HealthyActive, not recruitingPhase 12026-06-08NCT07565597
A Study of ZG006 for Injection Versus Investigator-Selected Chemotherapy in Participants With Advanced Neuroendocrine CarcinomaNeoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumorNot yet recruitingPhase 32026-05-19NCT07595913
Study of ZG005 in Combination With Platinum-Based Chemotherapy in Participants With Advanced Biliary Tract CarcinomaBiliary Tract CarcinomaRecruitingPhase 22026-05-01NCT07099547
Study of ZG005 in Patients With Advanced Solid TumorsAdvanced Solid TumorActive, not recruitingPhase 22026-04-29NCT06927687
Study of ZGGS34 in Participants With Advanced Solid TumorsSolid TumorRecruitingPhase 1 / Phase 22026-04-28NCT07258121
Study of ZG006 in Combination With PD-1/PD-L1 Immune Checkpoint Inhibitors as First-Line Standard Therapy in Participants With Extensive Stage Small-Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 12026-04-28NCT07231445
Study Comparing ZG006 With Investigator-Selected Chemotherapy in Participants With Relapsed Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 32026-01-05NCT07189455
Study of ZG005 in Combination With Gecacitinib in Participants With Advanced Cervical CancerFemale Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, neoplasm, uterine disorderRecruitingPhase 1 / Phase 22026-01-05NCT07080216
ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine CarcinomaNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 1 / Phase 22026-01-05NCT07038096
Study of ZGGS18 in Combination With ZG005 in Patients With Advanced Solid TumorsAdvanced Solid TumorRecruitingPhase 1 / Phase 22026-01-05NCT06938880
Study of ZG005 Combined With Gecacitinib in Patients With Advanced Non-Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 1 / Phase 22026-01-05NCT06903377
Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory LymphomaHemic and Lymphatic Diseases, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasmRecruitingPhase 1 / Phase 22026-01-05NCT06883526
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine CarcinomaNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 1 / Phase 22026-01-05NCT05978284
Study of ZGGS18 in Patients With Advanced Solid TumorsAdvanced Solid TumorRecruitingPhase 1 / Phase 22026-01-05NCT05584800
A Phase III Study of Jaktinib in Adults With Moderate and Severe Atopic DermatitisCongenital, Hereditary, and Neonatal Diseases and Abnormalities, Hypersensitivity, Immediate, Skin Diseases, Eczematous, Skin and Connective Tissue Diseases, atopic eczema, dermatitis, hereditary disease, hereditary skin disorder, immune system disorder, skin disorderActive, not recruitingPhase 32026-01-05NCT05526222
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung CancerNeoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Thoracic Neoplasms, adenocarcinoma, bronchial neoplasm, bronchogenic carcinoma, carcinoma, epithelial neoplasm, lung disorder, lung neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 1 / Phase 22025-11-17NCT06283719
Study of ZG005 in Combination With Gecacitinib and Chemotherapy for Participants With Advanced Solid TumorsAdvanced Solid TumorNot yet recruitingPhase 1 / Phase 22025-08-27NCT07142837
A Phase 1 Dose Escalation Study of ZG006 in Patients With Small Cell Lung CancerNeoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinomaRecruitingPhase 12025-08-06NCT06592638
Study of ZG006 in Participants With Neuroendocrine Prostate CancerNeuroendocrine Prostate CancerNot yet recruitingPhase 22025-06-17NCT07024277
Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular CarcinomaDigestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasmRecruitingPhase 22024-12-16NCT06558227
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Neuroendocrine Carcinoma.Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, adenocarcinoma, carcinoma, epithelial neoplasm, neoplasm, neuroendocrine carcinoma, neuroendocrine neoplasm, primitive neuroectodermal tumorRecruitingPhase 1 / Phase 22024-12-16NCT06440057